FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ulrike Bacher

Research Profile

Disorders

Procedures

Concepts & Ideas

Anatomy

Occupations

Cytogenetics

Physiology

Disease Progression

Co-author Network

Publications

TOP 3
Ulrike Bacher; Susanne Schnittger; Wolfgang Kern; Guido Trenn; Martin Weisser; Torsten Haferlach; Claudia Schoch
Acute myeloid leukemia (AML) with t(8;21)(q22;q22) relapsing as AML with t(3;21)(q26;q22).
Ulrike Bacher; Andreas Reiter; Torsten Haferlach; Lothar Mueller; Susanne Schnittger; Wolfgang Kern; Claudia Schoch
A combination of cytomorphology, cytogenetic analysis, fluorescence in situ hybridization and reverse transcriptase polymerase chain reaction for establishing clonality in cases of persisting hypereosinophilia.
Ulrike Bacher; Wolfgang Kern; Claudia Schoch; Susanne Schnittger; Wolfgang Hiddemann; Torsten Haferlach
Evaluation of complete disease remission in acute myeloid leukemia: a prospective study based on cytomorphology, interphase fluorescence in situ hybridization, and immunophenotyping during follow-up in patients with acute myeloid leukemia.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ulrike Bacher (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2006: Ulrike Bacher; Susanne Schnittger; Wolfgang Kern; Guido Trenn; Martin Weisser; Torsten Haferlach; Claudia Schoch
Acute myeloid leukemia (AML) with t(8;21)(q22;q22) relapsing as AML with t(3;21)(q26;q22).
Cancer genetics and cytogenetics 2006;168(2):172-4.
2006: Ulrike Bacher; Andreas Reiter; Torsten Haferlach; Lothar Mueller; Susanne Schnittger; Wolfgang Kern; Claudia Schoch
A combination of cytomorphology, cytogenetic analysis, fluorescence in situ hybridization and reverse transcriptase polymerase chain reaction for establishing clonality in cases of persisting hypereosinophilia.
Haematologica 2006;91(6):817-20.
2006: Ulrike Bacher; Wolfgang Kern; Claudia Schoch; Susanne Schnittger; Wolfgang Hiddemann; Torsten Haferlach
Evaluation of complete disease remission in acute myeloid leukemia: a prospective study based on cytomorphology, interphase fluorescence in situ hybridization, and immunophenotyping during follow-up in patients with acute myeloid leukemia.
Cancer 2006;106(4):839-47.
2005: Ulrike Bacher; Wolfgang Kern; Susanne Schnittger; Wolfgang Hiddemann; Torsten Haferlach; Claudia Schoch
Population-based age-specific incidences of cytogenetic subgroups of acute myeloid leukemia.
Haematologica 2005;90(11):1502-10.
2005: Ulrike Bacher; Wolfgang Kern; Susanne Schnittger; Wolfgang Hiddemann; Claudia Schoch; Torsten Haferlach
Further correlations of morphology according to FAB and WHO classification to cytogenetics in de novo acute myeloid leukemia: a study on 2,235 patients.
Annals of hematology 2005;84(12):785-91.
2005: Ulrike Bacher; Torsten Haferlach; Claudia Schoch
Gain of 9p due to an unbalanced rearrangement der(9;18): a recurrent clonal abnormality in chronic myeloproliferative disorders.
Cancer genetics and cytogenetics 2005;160(2):179-83.
2005: Ulrike Bacher; Torsten Haferlach; Wolfgang Kern; Wolfgang Hiddemann; Susanne Schnittger; Claudia Schoch
Conventional cytogenetics of myeloproliferative diseases other than CML contribute valid information.
Annals of hematology 2005;84(4):250-7.
2005: Ulrike Bacher; Wolfgang Kern; Susanne Schnittger; Wolfgang Hiddemann; Claudia Schoch; Torsten Haferlach
Blast count and cytogenetics correlate and are useful parameters for the evaluation of different phases in chronic myeloid leukemia.
Leukemia & lymphoma 2005;46(3):357-66.
2005: Ulrike Bacher; Torsten Haferlach; Wolfgang Hiddemann; Susanne Schnittger; Wolfgang Kern; Claudia Schoch
Additional clonal abnormalities in Philadelphia-positive ALL and CML demonstrate a different cytogenetic pattern at diagnosis and follow different pathways at progression.
Cancer genetics and cytogenetics 2005;157(1):53-61.
2004: Ulrike Bacher; Wolfgang Kern; Claudia Schoch; Wolfgang Hiddemann; Torsten Haferlach
Discrimination of chronic lymphocytic leukemia (CLL) and CLL/PL by cytomorphology can clearly be correlated to specific genetic markers as investigated by interphase fluorescence in situ hybridization (FISH).
Annals of hematology 2004;83(6):349-55.